Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR, Fokam J, Njume D, Takou D, Santoro MM, Nyasa RB, Chenwi C, Mpouel ML, Beloumou G, Jagni ESN, Nka AD, Ka'e AC, Teto G, Dambaya B, Djupsa S, Gouissi Anguechia DH, Evariste M, Kamta C, Bala L, Lambo V, Halle-Ekane EG, Colizzi V, Perno CF, Ndjolo A, Ndip Ndip R. Togna Pabo WLR, et al. Among authors: santoro mm. PLoS One. 2023 Oct 25;18(10):e0293326. doi: 10.1371/journal.pone.0293326. eCollection 2023. PLoS One. 2023. PMID: 37878637 Free PMC article.
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.
Svicher V, Sing T, Santoro MM, Forbici F, Rodríguez-Barrios F, Bertoli A, Beerenwinkel N, Bellocchi MC, Gago F, d'Arminio Monforte A, Antinori A, Lengauer T, Ceccherini-Silberstein F, Perno CF. Svicher V, et al. Among authors: santoro mm. J Virol. 2006 Jul;80(14):7186-98. doi: 10.1128/JVI.02084-05. J Virol. 2006. PMID: 16809324 Free PMC article.
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors.
Ceccherini-Silberstein F, Svicher V, Sing T, Artese A, Santoro MM, Forbici F, Bertoli A, Alcaro S, Palamara G, d'Arminio Monforte A, Balzarini J, Antinori A, Lengauer T, Perno CF. Ceccherini-Silberstein F, et al. Among authors: santoro mm. J Virol. 2007 Oct;81(20):11507-19. doi: 10.1128/JVI.00303-07. Epub 2007 Aug 8. J Virol. 2007. PMID: 17686836 Free PMC article.
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.
Santoro MM, Bertoli A, Lorenzini P, Lazzarin A, Esposito R, Carosi G, Di Perri G, Filice G, Moroni M, Rizzardini G, Caramello P, Maserati R, Narciso P, Cargnel A, Antinori A, Perno CF; CARe Study Group. Santoro MM, et al. AIDS Patient Care STDS. 2008 Jan;22(1):7-16. doi: 10.1089/apc.2007.0013. AIDS Patient Care STDS. 2008. PMID: 18095835 Clinical Trial.
Dynamics of NRTI resistance mutations during therapy interruption.
Trignetti M, Sing T, Svicher V, Santoro MM, Forbici F, D'arrigo R, Bellocchi MC, Santoro M, Marconi P, Zaccarelli M, Trotta MP, Bellagamba R, Narciso P, Antinori A, Lengauer T, Perno CF, Ceccherini-Silberstein F. Trignetti M, et al. Among authors: santoro m, santoro mm. AIDS Res Hum Retroviruses. 2009 Jan;25(1):57-64. doi: 10.1089/aid.2008.0159. AIDS Res Hum Retroviruses. 2009. PMID: 19182921
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
Zaccarelli M, Antinori A, Cozzi-Lepri A, Mussini C, Palamara G, Santoro MM, Spagnuolo V, Monforte Ad, Perno CF, Ceccherini-Silberstein F. Zaccarelli M, et al. Among authors: santoro mm. J Acquir Immune Defic Syndr. 2010 Jan;53(1):150-1. doi: 10.1097/QAI.0b013e3181c428b4. J Acquir Immune Defic Syndr. 2010. PMID: 20035165 No abstract available.
331 results